Biosurgery Market Size to Reach US$ 18.2 Billion by 2027 | IMARC Group

According to the latest report by IMARC Group, titled “Biosurgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global biosurgery market reached a value of US$ 12.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.2 Billion by 2027, exhibiting a CAGR of 6.95% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Industry Definition and Application:

Biosurgery is a medical practice of cleaning a wound or contaminated area with live organisms, such as larvae or maggots. It is extensively used to prevent excessive blood loss, provide adhesion for injury or tissue sealing, and repair damaged tissues and bones. It includes biological and synthetic materials used during surgery to eliminate complications, improve surgical practices, and meet various surgical needs, such as preventing excess bleeding, reducing the risks of infection, and debridement of the necrotic, slough, devitalized wounds or tissues and defects.

Request Free Sample Report: https://www.imarcgroup.com/biosurgery-market/requestsample

Market Trends:

The global market is majorly driven by the growing number of surgical procedures. In line with this, the availability of multifunctional products that accelerate healing and help reduce post-surgical recovery duration is positively influencing the market. Heavy investments by governments of various countries to boost public healthcare delivery are acting as another growth-inducing factor. Furthermore, the rising demand for effective patient blood loss management is catalyzing the market.

Moreover, the increasing health awareness, expanding healthcare expenditure, growing medical tourism, and fast improving healthcare infrastructure are offering numerous growth opportunities in the biosurgery market. Besides this, the high prevalence of diabetes and spinal injuries among the masses is propelling the demand for biosurgery. Additionally, the escalating demand for minimally invasive surgeries and a continual rise in the aging population with chronic conditions are strengthening the growth of the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 18.2 Billion by 2027, exhibiting a CAGR of 6.95% during 2022-2027. 

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

• Bone-Graft Substitutes
• Soft-Tissue Attachments
• Hemostatic Agents
• Surgical Sealants and Adhesives
• Adhesion Barriers
• Staple Line Reinforcement

Breakup by Source:

• Natural/Biologics Products
• Synthetic Products

Breakup by Application:

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Others

Breakup by End User:

• Hospitals
• Clinics
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Competitive Landscape with Key Player:

• B. Braun Melsungen AG
• Baxter International Inc
• Becton Dickinson and Company
• CryoLife Inc
• CSL Limited
• Hemostasis LLC
• Integra Lifesciences Holdings Corporation
• Johnson & Johnson
• Medtronic plc
• Pfizer Inc
• Sanofi S.A
• Smith & Nephew plc
• Stryker Corporation
• Surgalign Spine Technologies Inc

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4522&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group